Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Induction of AMPK phosphorylation at Thr172 in human TE671 cells at 50 to 100 uM after 4 hrs by immunoblot analysis in presence of CAMMK-beta inhibitor STO-609
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Activation of AMPK in human HepG2 cells assessed as reduction of gluconeogenesis at 50 uM after 24 hrs by enzymatic colorimetric assay relative to control
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Activation of AMPK in human HepG2 cells assessed as reduction of gluconeogenesis at 100 uM after 24 hrs by enzymatic colorimetric assay relative to control
Activation of AMPK in human HepG2 cells assessed as reduction of gluconeogenesis at 1 mM after 24 hrs by enzymatic colorimetric assay
Activation of AMPK in human TE671 cells assessed as increase in glucose uptake by measuring intracellular 2-NBDG level at 100 uM after 24 hrs by fluorimetric analysis relative to control
Activation of AMPK in human TE671 cells assessed as increase in glucose uptake by measuring intracellular 2-NBDG level at 100 uM after 24 hrs by fluorimetric analysis in presence of insulin relative to control
Induction of AMPK phosphorylation at Thr172 in human HepG2 cells at 50 to 100 uM after 4 hrs by immunoblot analysis
Induction of AMPK phosphorylation at Thr172 in human TE671 cells at 50 to 100 uM after 4 hrs by immunoblot analysis
Activation of AMPK (unknown origin) by luminescence assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Induction of AMPK phosphorylation at Thr172 in human HepG2 cells at 50 to 100 uM after 4 hrs by immunoblot analysis in presence of CAMMK-beta inhibitor STO-609
Inhibition of AMPK (unknown origin) at 250 nM by radioactive filter-binding assay
Activation of AMPK in human HepG2 cells assessed as induction of CRTC2 phosphorylation at 100 uM after 4 hrs by immunoblot analysis relative to control
Activation of AMPK in human HepG2 cells assessed as induction of HDAC5 phosphorylation at 100 uM after 4 hrs by immunoblot analysis relative to control
Activation of AMPK in human HepG2 cells assessed as decrease in CRTC2 level in nucleus at 100 uM after 4 hrs by immunoblot analysis relative to control
Activation of AMPK in human HepG2 cells assessed as decrease in HDAC5 level in nucleus at 100 uM after 4 hrs by immunoblot analysis relative to control
Activation of AMPK in human HepG2 cells assessed as reduction of CREB transactivation at 50 to 100 uM after 24 hrs by luciferase reporter gene assay relative to control
Activation of AMPK in human HepG2 cells assessed as reduction of FoxO1 transactivation at 50 to 100 uM after 24 hrs by luciferase reporter gene assay relative to control
Activation of AMPK in human HepG2 cells assessed as reduction of CRTC2 binding to PEPCK promoter at 50 to 100 uM by ChIP assay relative to control
Activation of AMPK in human HepG2 cells assessed as reduction of CRTC2 binding to G6Pase promoter at 50 to 100 uM by ChIP assay relative to control
Activation of AMPK in human HepG2 cells using ACC as substrate after 2 hrs
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on